PL367931A1 - Sposób wytwarzania kwasu 2-[N-[(S)-1-etoksykarbonylo-3-fenylopropylo]-(S)-alanylo]-(1S,3S,5S)-2-azabicyklo[3.3.0]oktano-3-karboksylowego - Google Patents

Sposób wytwarzania kwasu 2-[N-[(S)-1-etoksykarbonylo-3-fenylopropylo]-(S)-alanylo]-(1S,3S,5S)-2-azabicyklo[3.3.0]oktano-3-karboksylowego

Info

Publication number
PL367931A1
PL367931A1 PL04367931A PL36793104A PL367931A1 PL 367931 A1 PL367931 A1 PL 367931A1 PL 04367931 A PL04367931 A PL 04367931A PL 36793104 A PL36793104 A PL 36793104A PL 367931 A1 PL367931 A1 PL 367931A1
Authority
PL
Poland
Prior art keywords
etoxycarbonyl
alanyl
azabicyclo
octane
manufacture
Prior art date
Application number
PL04367931A
Other languages
English (en)
Inventor
Krzysztof Bańkowski
Teresa Wachal
Katarzyna Sidoryk
Wiesław Szelejewski
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Priority to PL04367931A priority Critical patent/PL367931A1/pl
Priority to EP05740364A priority patent/EP2112992A1/en
Priority to PCT/PL2005/000029 priority patent/WO2005108366A1/en
Priority to US11/568,922 priority patent/US20080234493A1/en
Publication of PL367931A1 publication Critical patent/PL367931A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL04367931A 2004-05-12 2004-05-12 Sposób wytwarzania kwasu 2-[N-[(S)-1-etoksykarbonylo-3-fenylopropylo]-(S)-alanylo]-(1S,3S,5S)-2-azabicyklo[3.3.0]oktano-3-karboksylowego PL367931A1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL04367931A PL367931A1 (pl) 2004-05-12 2004-05-12 Sposób wytwarzania kwasu 2-[N-[(S)-1-etoksykarbonylo-3-fenylopropylo]-(S)-alanylo]-(1S,3S,5S)-2-azabicyklo[3.3.0]oktano-3-karboksylowego
EP05740364A EP2112992A1 (en) 2004-05-12 2005-05-12 A process for the preparation of -2-n [(s)-1-ethoxycarbonyl-3-phenylpropyl]-(s)-alanyl]-(1s, 3s, 5s)-2-azabicyclo [3.3.0] octane-3-carboxylic acid
PCT/PL2005/000029 WO2005108366A1 (en) 2004-05-12 2005-05-12 A process for the preparation of 2-[n-­ [(s)-1-ethoxycarbonyl-3-phenylpropyl]-(s)-alanyl]-(1s, 3s, 5s) -2-azabicyclo [3.3.0] octane-3­-carboxylic acid
US11/568,922 US20080234493A1 (en) 2004-05-12 2005-05-12 Process for the Preparation of 2-[N-[{S)-1-Ethoxycarbonyl-3-Phenylpropyl]-(S)-Alanyl]-(1S,3S,5S)-2-Azabicyclo[3.3.0]Oct- an-3-Carboxylic Acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL04367931A PL367931A1 (pl) 2004-05-12 2004-05-12 Sposób wytwarzania kwasu 2-[N-[(S)-1-etoksykarbonylo-3-fenylopropylo]-(S)-alanylo]-(1S,3S,5S)-2-azabicyklo[3.3.0]oktano-3-karboksylowego

Publications (1)

Publication Number Publication Date
PL367931A1 true PL367931A1 (pl) 2005-11-14

Family

ID=34969771

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04367931A PL367931A1 (pl) 2004-05-12 2004-05-12 Sposób wytwarzania kwasu 2-[N-[(S)-1-etoksykarbonylo-3-fenylopropylo]-(S)-alanylo]-(1S,3S,5S)-2-azabicyklo[3.3.0]oktano-3-karboksylowego

Country Status (4)

Country Link
US (1) US20080234493A1 (pl)
EP (1) EP2112992A1 (pl)
PL (1) PL367931A1 (pl)
WO (1) WO2005108366A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20120460T1 (hr) 2007-06-06 2012-06-30 Dsm Sinochem Pharmaceuticals Netherlands B.V. Novi 5-supstituirani hidantoini
EP2207768A1 (en) * 2007-11-13 2010-07-21 DSM IP Assets B.V. Improved ramipril synthesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226768A1 (de) * 1981-11-05 1983-05-26 Hoechst Ag, 6230 Frankfurt Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
SI9600169A (en) * 1996-05-22 1997-12-31 Krka Tovarna Zdravil Process for preparation of compounds with ace inhibitory effect
US6407262B1 (en) * 2001-11-21 2002-06-18 Brantford Chemicals Inc. Process for the preparation of Ramipril
CA2363658C (en) * 2001-11-21 2005-12-13 Brantford Chemicals Inc. Improved process for the preparation of ramipril

Also Published As

Publication number Publication date
WO2005108366A1 (en) 2005-11-17
EP2112992A1 (en) 2009-11-04
US20080234493A1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
SI1656346T1 (sl) 1,2,3,4-tetrasubstituiran indol za zdravljenje respiratornih bolezni
DE602005026031D1 (de) Kristalline formen von (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid zur verwendung als aktivstoff in pharmazeutischen zubereitungen
ZA200806066B (en) Process for the preparation of 6,6-dimethyl-3-azabicyclo[3.1.0]-hexane compounds and enantiomeric salts thereof
WO2007070504A3 (en) Stable and palatable oral liquid sumatriptan compositions
WO2003043631A3 (en) Method for identification of tumor targeting enzymes
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
HUE037069T2 (hu) Eljárás nagy tisztaságú 2,4'-metiléndifenildiizocianát elõállítására
HRP20050328A2 (en) Process for the preparation of (s,s)-cis-2-benzhyd
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
IL186465A0 (en) Process for preparing levetiracetam and racemization of (r)-and(s)-2-amino butynamide and the corresponding acid derivatives
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
MEP55308A (en) New pharmaceutical compositions containing flibanserin polymorph a
HUP0202414A3 (en) Process for the preparation of perindopril, their analogous and their salts
TW200716204A (en) Pharmaceutical composition
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
WO2004081199A3 (en) Novel compositions and methods for the treatment of immune related disease
EA200970590A1 (ru) Антагонисты crth2
PT1499587E (pt) Processo para síntese de sais de dissulfureto farmaceuticamente activos
PL367931A1 (pl) Sposób wytwarzania kwasu 2-[N-[(S)-1-etoksykarbonylo-3-fenylopropylo]-(S)-alanylo]-(1S,3S,5S)-2-azabicyklo[3.3.0]oktano-3-karboksylowego
AP2006003613A0 (en) Oral formulations for 5-HT-receptor agonists, usesand methods of treatment employing the same
AU2002325614A1 (en) Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
WO2007144699A3 (en) Process for the preparation of alfuzosin
PL1753720T3 (pl) Proces wytwarzania peryndoprylu i jego soli
AU2003268706A1 (en) PROCESS FOR PRODUCING OPTICALLY ACTIVE Alpha-SUBSTITUTED CYSTEINE OR SALT THEREOF, INTERMEDIATE THEREFOR, AND PROCESS FOR PRODUCING THE SAME

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed